Infectious Agents and Cancer is affiliated with the African Organisation for Research & Training In Cancer (AORTIC)
Articles
Page 21 of 23
-
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P41
-
Kaposi's sarcoma human herpesvirus K1 interferes with FAS-mediated apoptosis and stimulates clonal growth and lymphoid hyperplasia
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P37 -
HIV-associated bladder cancer: diagnosis and management
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P34 -
Colon adenocarcinoma in HIV infected patients
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P32 -
Extracellular matrix promotes pathogenic treatment of AIDS-associated Kaposi's sarcoma at Hôpital General in Yaoundé, Cameroon
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P30 -
Genetic resistance to GAHV-2 induced lymphoma in the chicken model
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P28 -
Genetically restricted HIV-1 sub populations are associated with and migrate within metastatic sites of AIDS-related lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P27 -
MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survival
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P26 -
Risk of death among Italian AIDS cases with AIDS-defining cancers in the post-HAART era
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O25 -
Tobacco, alcohol and use of other recreational drugs within HIV-infected treated cohorts: the IeDEA West Africa collaboration
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P24 -
Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in AIDS-associated non-Hodgkin's lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O24 -
Trends in cancer incidence among HIV-infected persons in California, 1996–2006
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O22 -
Burkitt lymphoma in Brazil is characterized by geographically distinct clinico-pathological features and lack of p53 mutations
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P22 -
Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O20 -
KSHV seroprevalence, and blood and saliva viral loads in the HIV-infected population of south Texas
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P20 -
Preliminary findings on cancer incidence in HIV-infected persons from six countries in Central and South America and the Caribbean
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O18 -
Kaposi's sarcoma-associated herpes virus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P18 -
Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O17 -
Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O16 -
Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O15 -
Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O14 -
Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P13 -
Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O12 -
Epidemiology of non-keratinocytic skin cancers among persons with AIDS in the United States
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O10 -
Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P6 -
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O6 -
AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O5 -
A population-based study of how children are exposed to saliva in Africa: implications for KSHV transmission
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O4 -
Malignancies in HIV infected children at a tertiary cancer hospital in India
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P4 -
Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O3 -
Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O2 -
Development and application of a real time PCR assay for detection and quantification of merkel cell virus (MCV) in archived formalin fixed paraffin embedded tissue samples of merkel cell carcinoma and other cancers
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O1 -
Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy
Women infected with human immunodeficiency virus (HIV) may be at higher risk of developing cervical cancer than non infected women. In a pilot study, we assessed the relationships among cervical cytology abnor...
Citation: Infectious Agents and Cancer 2009 4:9 -
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
Virtually all cases of cervical cancer are caused by persistent infections with a restricted set of human papillomaviruses (HPV). Some HPV types, like HPV16 and HPV18, are clear and powerful carcinogens. Howev...
Citation: Infectious Agents and Cancer 2009 4:8 -
The evolving definition of carcinogenic human papillomavirus
Thirteen human papillomavirus (HPV) genotypes have been judged to be carcinogenic or probably carcinogenic, and the cause of virtually all cervical cancer worldwide. Other HPV genotypes could possibly be invol...
Citation: Infectious Agents and Cancer 2009 4:7 -
Analysis of colorectal cancers for human cytomegalovirus presence
A possible association between human cytomegalovirus (HCMV) infection and colorectal cancer progression has been inferred by the identification in tumour tissues of HCMV antigens and specific viral DNA or RNA ...
Citation: Infectious Agents and Cancer 2009 4:6 -
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Correction to Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O: Antiviral therapy in acute viral hepatitis B: why and when. Infectious Agents and Cancer 2009, 4:2.
Citation: Infectious Agents and Cancer 2009 4:5 -
Cancer risk in persons with HIV/AIDS in India: a review and future directions for research
India has a large and evolving HIV epidemic. Little is known about cancer risk in Indian persons with HIV/AIDS (PHA) but risk is thought to be low.
Citation: Infectious Agents and Cancer 2009 4:4 -
Human papillomavirus type 16 variants in cervical intraepithelial neoplasia and invasive carcinoma in San Luis Potosà City, Mexico
In San Luis Potosà City cervical infection by human papillomavirus type 16 (HPV16) associated to dysplastic lesions is more prevalent in younger women. In this work HPV16 subtypes and variants associated to lo...
Citation: Infectious Agents and Cancer 2009 4:3 -
Fear and loathing in the Caribbean: three studies of fear and cancer screening in Brooklyn's immigrant Caribbean subpopulations
Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S14 -
Knowledge about human papillomavirus and the HPV vaccine – a survey of the general population
The United States (US) Food & Drug Administration (FDA) recently approved a human papillomavirus (HPV) vaccine with the purpose of reducing the risk of cervical cancers caused by HPV 16 and HPV 18. It is impor...
Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S10 -
Comparisons of high-risk cervical HPV infections in Caribbean and US populations
Disparities in cervical cancer incidence and mortality rates exist among women of African ancestry (African-American, African-Caribbean and African). Persistent cervical infection with Human papillomavirus (HP...
Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S9 -
The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virus
The human papillomavirus (HPV) is the major etiologic agent in the development of cervical cancer and its natural history of infection is altered in persons infected with the human immunodeficiency virus (HIV)...
Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S8 -
Ethnicity and cancer in Guyana, South America
The Cancer Registry of Guyana, a population-based registry was established in 2000. Over the past eight years, data has been collected from the national referral hospital and other public and private instituti...
Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S7 -
Association of self-reported consumption of cooked meat, fish, seafood and eggs with prostate cancer risk among Nigerians
Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S6 -
Are food patterns associated with prostate cancer in Jamaican men: a preliminary report
Morbidity and mortality data highlight prostate cancer as the most commonly diagnosed neoplasm in Jamaican males. This report examines the association between dietary patterns and risk of prostate cancer in Ja...
Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S5 -
Surgical versus medical castration in the Bahamas: a male macho paradox
Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S4 -
Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: a pilot project study
African American Men are 65% more likely to develop prostate cancer and are twice as likely to die of prostate cancer, than are Caucasian American Males. The explanation for this glaring health disparity is st...
Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S3 -
Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa
African American men have the highest prostate cancer morbidity and mortality rates than any other racial or ethnic group in the US. Although the overall incidence of and mortality from prostate cancer has bee...
Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S2 -
The Second International African-Caribbean Cancer Consortium for the study of viral, genetic and environmental cancer risk factors
Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S1
-
Affiliated with
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Editors' Profile
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
2022 Citation Impact
3.7 - 2-year Impact Factor
3.8 - 5-year Impact Factor
1.040 - SNIP (Source Normalized Impact per Paper)
0.583 - SJR (SCImago Journal Rank)2023 Speed
14 days submission to first editorial decision for all manuscripts (Median)
112 days submission to accept (Median)2023 Usage
687,750 downloads
813 Altmetric mentions
What is trending?
Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.